What is PBYI stock price today?

Visit our real-time dashboard for the current PBYI stock price and live market data.

Is PBYI stock going up or down today?

PBYI stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy PBYI stock now?

The decision to buy PBYI depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is PBYI a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for PBYI based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is PBYI stock overvalued or undervalued?

PBYI currently trades at a P/E ratio of 4.27, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if PBYI is fairly priced.

What is PBYI's P/E ratio?

PBYI has a price-to-earnings (P/E) ratio of 4.27, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is PBYI's market cap?

PBYI (Puma Biotechnology Inc) has a market capitalization of $0.17 billion, making it a small-cap stock.

What is PBYI's price to book ratio?

Price-to-book ratio for PBYI is available on our dashboard along with other valuation metrics.

Does PBYI pay dividends?

PBYI does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is PBYI's dividend yield?

PBYI does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is PBYI stock a good long-term investment?

PBYI's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is PBYI's revenue growth rate?

Revenue growth data for PBYI is available on our dashboard with detailed financial statement analysis.

Profitability metrics for PBYI are available on our dashboard with complete income statement analysis.

What are the risks of investing in PBYI?

Key risks for PBYI include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does PBYI compare to its competitors?

Compare PBYI to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize PBYI's performance and positioning.

What is PBYI's stock price target for 2026?

Visit our prediction page for AI-powered price targets for PBYI with bull, base, and bear case scenarios.

What do analysts say about PBYI?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for PBYI. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is PBYI's next earnings report?

PBYI reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

PBYI - Puma Biotechnology Inc

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Puma Biotechnology Inc

Puma Biotechnology Inc (PBYI) common stock

Price Chart

Loading chart...

PBYI Key Statistics

Market Cap

$165.29M

P/E Ratio

4.27

How PBYI Compares to Peers

PBYI has the lowest P/E ratio in Biotechnology, suggesting it may be the most undervalued

PBYI is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
PBYI(This stock)	$165.29M	4.3	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 17, 2026 at 3:05 AM EDT

Ready to invest in PBYI?

Commission-free trading available. Affiliate links.

PBYI Lician Score

10% confidence

6.0/10

Good

PBYI has a Lician Score of 6/10 (Good). Strengths: Growth.

value

5.0

growth

8.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates PBYIacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

PBYI Financial Snowflake

5-axis analysis across key investment dimensions

5.6/10

Neutral

5.0

Value

Valuation vs. sector peers

8.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for PBYI

Dashboard

Enter a ticker to analyze